Ascendis Pharma A (ASND) Price to Sales (2015 - 2026)
Ascendis Pharma A's (ASND) Price to Sales came in at 13.54 for the quarter ended Jun 30, 2026, down 30.9% from 19.60 a year earlier and down 4.0% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Price to Sales (2015 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Ascendis Pharma A's Price to Sales stood at 16.24, down 14.6% from the prior year.
- Annual Price to Sales has declined for five consecutive years.
- In prior years, Ascendis Pharma A's Price to Sales was 19.02 in the year ended Dec 31, 2024 (-24.5%), 25.19 in the year ended Dec 31, 2023 (-80.5%), 129.41 in the year ended Dec 31, 2022 (-85.0%) and 860.87 in the year ended Dec 31, 2021 (-20.4%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Price to Sales since the quarter ended Mar 31, 2015.
- On a year-over-year basis, Price to Sales has declined in each of the last three quarters, with an average decline of 3.9% over the last eight quarters.
- The strongest year-over-year quarter for Price to Sales in the past five years was the quarter ended Dec 31, 2022, with growth of 75.3%; the weakest was the quarter ended Dec 31, 2023, with a decline of 88.1%.
- According to Business Quant data, Price to Sales for the three prior quarters was 14.10 (quarter ended Mar 31, 2026), 16.06 (quarter ended Dec 31, 2025) and 16.74 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Ascendis Pharma A | 14.09 Bn | 10.33 Bn | 362.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.54 |
| Mar 31, 2026 | 14.10 |
| Dec 31, 2025 | 16.06 |
| Sep 30, 2025 | 16.74 |
| Jun 30, 2025 | 19.60 |
| Mar 31, 2025 | 23.99 |
| Dec 31, 2024 | 21.30 |
| Sep 30, 2024 | 16.19 |
| Jun 30, 2024 | 15.11 |
| Mar 31, 2024 | 16.34 |
| Dec 31, 2023 | 15.61 |
| Sep 30, 2023 | 32.77 |
| Jun 30, 2023 | 40.34 |
| Mar 31, 2023 | 75.28 |
| Dec 31, 2022 | 131.67 |
| Sep 30, 2022 | 45.87 |
| Jun 30, 2022 | 46.40 |
| Mar 31, 2022 | 61.45 |
| Dec 31, 2021 | 75.12 |
| Sep 30, 2021 | 99.80 |
API Access
Ascendis Pharma A Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();